Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils ... U.S. INDICATIONS DUPIXENT is a prescription medicine used: to treat adults and children 6 months ...

could benefit from the funding of a new medicine. The Pharmac funding will allow people suffering from COPD to switch from ...

Dr MeiLan Han, a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health, discusses the impact inadequately controlled COPD has on daily ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils ... and consistently translate science into medicine has led to numerous approved treatments and ...